CIK 0001001233
- Non-accelerated filer
- Smaller reporting company
SANGAMO THERAPEUTICS, INC
Sign in to watch- Ticker
- SGMOQ
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 680359556
- Phone
- +1 510-970-6000
- Business address
- 501 CANAL BLVD., RICHMOND, CA, 94084
- Former names
- SANGAMO BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-22 | Davis Gregory D Head of Research & Technology | Sale | −69,827 | $0.25 | $18K | 115,284 |
| 2026-04-21 | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER | Sale | −345,942 | $0.26 | $89K | 332,769 |
| 2023-09-26 | BIOGEN INC. 10% owner | Sale | −6,000,000 | $0.50 | $3.0M | 17,652,466 |
| 2022-08-30 | BIOGEN INC. 10% owner | Sale | −100,000 | $5.27 | $527K | 23,652,466 |
| 2022-08-29 | BIOGEN INC. 10% owner | Sale | −400,000 | $5.33 | $2.1M | 23,752,466 |
| 2021-12-28 | BIOGEN INC. 10% owner | Sale | −2,764 | $8.51 | $24K | 24,152,466 |
| 2021-12-27 | BIOGEN INC. 10% owner | Sale | −600 | $8.56 | $5K | 24,155,230 |
| 2021-12-23 | BIOGEN INC. 10% owner | Sale | −81,187 | $8.55 | $695K | 24,155,830 |
| 2021-12-09 | BIOGEN INC. 10% owner | Sale | −23,660 | $8.56 | $203K | 24,237,017 |
| 2021-12-08 | BIOGEN INC. 10% owner | Sale | −75,814 | $8.64 | $655K | 24,260,677 |
| 2021-12-07 | BIOGEN INC. 10% owner | Sale | −52,178 | $8.52 | $444K | 24,336,491 |
| 2021-12-02 | BIOGEN INC. 10% owner | Sale | −1,874 | $8.51 | $16K | 24,388,669 |
| 2021-12-01 | BIOGEN INC. 10% owner | Sale | −730 | $8.52 | $6K | 24,390,543 |
| 2021-11-26 | BIOGEN INC. 10% owner | Sale | −28,884 | $8.60 | $248K | 24,391,273 |
| 2021-03-23 | LOEB GARY EVP, General Counsel & Sec. | Sale | −11,981 | $13.10 | $157K | 88,781 |
| 2021-03-23 | LOEB GARY EVP, General Counsel & Sec. | Sale | −5,000 | $13.18 | $66K | 83,781 |
| 2021-03-23 | LOEB GARY EVP, General Counsel & Sec. | Sale | −543 | $13.17 | $7K | 83,238 |
Page 1 of 1 · 17 trades